Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI

Study Title
A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)
Teva Identifier
ABS-AS-101
ClinicalTrials.gov Identifier
NCT01056159
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: Albuterol dry powder inhaler | Drug: Albuterol HFA MDI (hydrofluoroalkane metered dose inhaler)

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age group
Adult
Age Range
18 Years to 45 Years
Trial Duration
01/01/2010 - 06/01/2010
Phase
Phase 1

Study Type

Interventional